Foam fractionation studies of recombinant human apolipoprotein A-I
Apolipoprotein A-I (apoA-I), the primary protein component of plasma high-density lipoproteins (HDL), is comprised of two structural regions, an N-terminal amphipathic α-helix bundle domain (residues 1-184) and a hydrophobic C-terminal domain (residues ...
Fox, Colin A +6 more
core +1 more source
In vivo biological activity of a ApoA-I mimetic peptide.
Apolipoprotein A-I (ApoA-I), the major protein component of HDL, plays a key role in reverse cholesterol transport, mainly by stimulating the efflux of cholesterol and activating the enzyme LCAT.
CIGLIANO, LUISA +8 more
core
Genetic variants of lipid transport genes, dyslipidaemia and coronary heart disease.
PhDCoronary heart disease (CHD) is one of the most common causes of death in Western Countries. Genetic factors playa major role in the aetiology of CHD, however, the primary defects responsible for the disease have not been identified in most cases ...
Zhang, Qiuping
core
The disulfide-linked dimer of apolipoprotein A-IMilano (A-IM/A-IM), a natural Arg173 → Cys variant of apoA-I, was purified from carriers' plasma and produced in Escherichia coli.
A. HAMMARSTROM +12 more
core
Apolipoprotein A-I (apoA-I) is an exchangeable apolipoprotein that constitutes the major protein component of high density cholesterol. ApoA-I is a two-domain protein comprising an N-terminal helix bundle and a less-structured C-terminal domain in the ...
Rachel A. Ellena
core
The association between two common levels of apolipoprotein and chronic obstructive pulmonary disease: A Mendelian randomized study. [PDF]
Chen C +8 more
europepmc +1 more source
Retraction of: Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events [PDF]
openaire +1 more source
The association of ApoB/ApoA-I ratio with intracranial atherosclerotic stenosis in young patients with ischemic stroke. [PDF]
Yan M, Shao L.
europepmc +1 more source
Early ApoA-I Treatment Prevents Postsurgical Atherosclerotic Plaque Destabilization. [PDF]
Boucher DM +5 more
europepmc +1 more source
Artificial recombinant high-density protein nanocarriers for precision drug delivery. [PDF]
Li W, Jia N, Li M, Jiang Y, Lu J.
europepmc +1 more source

